← ANALYSTS · TIPRANKS
Phil Nadeau · TD Cowen
Hits
48%
229 of 476 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+8.7%
Over a year after the rating, TipRanks’ measure
Our companies rated now
20
Buy / hold / sell: 20 / 0 / 0
Upside of the analyst’s targets
+47.8%
Average over 5 current targets, to the last price
The market’s answer to the ratings
−4.4%
Day-0 move against SPY in the rating’s direction, average over 3 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 12on TipRanks 12:55 | SRZNIWMSurrozen · $295M | Reiterated | Buy | — | — | −16.5%next day −5.0% | ↗ |
| Oct 7on TipRanks Oct 8 05:55 | ELVNIWMEnliven Therapeutics · $2.9B | Reiterated | Buy | — | — | −2.2%next day −1.3% · 5 days −4.0% | ↗ |
| Oct 1on TipRanks 13:55 | MLTXMoonLake Immunotherapeutics · $873M | Reiterated | Buy | — | — | −2.1%next day −1.3% · 5 days −9.1% | ↗ |
| Sep 24on TipRanks 13:20 | CGEMIWMCullinan Management · $901M | Reiterated | Buy | — | — | −8.4%next day −4.6% · 5 days −5.5% | ↗ |
| Sep 2on TipRanks 11:10 | CABAIWMCabaletta Bio · $275M | Reiterated | Buy | — | — | +7.7%next day −3.6% · 5 days −22.3% | ↗ |
| Aug 20on TipRanks Aug 18 12:30 | BMRNBioMarin Pharmaceutical · $10.8B | Reiterated | Buy | $120 | +119.5% | +1.2%next day +3.3% · 5 days −1.1% | ↗ |
| Aug 12on TipRanks Aug 13 10:35 | KURAIWMKura Oncology · $863M | Reiterated | Buy | — | — | −0.2%next day +0.8% · 5 days +26.5% | ↗ |
| Aug 12on TipRanks Aug 13 10:35 | IPSCIWMCentury Therapeutics · $250M | Reiterated | Buy | — | — | −5.1%next day −2.2% · 5 days +8.1% | ↗ |
| Aug 12on TipRanks Aug 13 10:35 | ANNXIWMAnnexon Biosciences · $682M | Reiterated | Buy | — | — | −0.4%next day −2.0% · 5 days +3.6% | ↗ |
| Aug 10on TipRanks Aug 11 02:45 | NKTXIWMNkarta · $138M | Reiterated | Buy | — | — | +2.1%next day −5.0% · 5 days −1.2% | ↗ |
| Aug 10on TipRanks Aug 11 02:35 | MLTXMoonLake Immunotherapeutics · $873M | Reiterated | Buy | — | — | −5.1%next day −3.9% · 5 days −5.6% | ↗ |
| Aug 6on TipRanks Aug 7 04:00 | VYGRIWMVoyager Therapeutics · $124M | Reiterated | Buy | — | — | +1.1%next day +3.9% · 5 days +1.7% | ↗ |
| Aug 5on TipRanks Aug 6 06:05 | EDITIWMEditas Medicine · $375M | Reiterated | Buy | — | — | −0.5%next day +5.6% · 5 days +2.9% | ↗ |
| Aug 5on TipRanks Aug 6 06:05 | ELVNIWMEnliven Therapeutics · $2.9B | Reiterated | Buy | — | — | −2.1%next day +1.1% · 5 days −3.3% | ↗ |
| Aug 5on TipRanks Aug 6 06:00 | VIRIWMVir Biotechnology · $1.8B | Reiterated | Buy | — | — | −0.5%next day −3.6% · 5 days −2.0% | ↗ |
| Aug 4on TipRanks Aug 5 02:55 | SNDXIWMSyndax Pharmaceuticals · $1.2B | Reiterated | Buy | — | — | −2.6%next day +4.6% · 5 days +6.4% | ↗ |
| Aug 4on TipRanks Aug 5 02:50 | RYTMIWMRhythm Pharmaceuticals · $6.0B | Assigned | Buy | $130 | +50.9% | +1.1%next day +4.9% · 5 days +6.8% | ↗ |
| Aug 4on TipRanks Aug 3 23:30 | VRTXQQQSPYVertex Pharmaceuticals · $129B | Assigned | Buy | $525 → $550+4.8% | +10.1% | −0.1%next day +1.5% · 5 days +10.7% | ↗ |
| Jul 31on TipRanks Jul 30 22:45 | NBIXNeurocrine · $13.9B | Assigned | Buy | $200 → $220+10.0% | +62.1% | −10.8%next day −1.8% · 5 days −5.5% | ↗ |
| Jul 30on TipRanks Jul 29 19:10 | BIIBSPYBiogen · $34.8B | Assigned | Buy | $215 → $225+4.7% | −3.3% | −2.3%next day −3.1% · 5 days −4.4% | ↗ |
| May 11on TipRanks 18:35 | AURAIWMAura Biosciences Inc · $657M | Reiterated | Buy | — | — | −3.0%next day +0.6% · 5 days −6.2% | ↗ |
| May 7on TipRanks 01:06 | SRZNIWMSurrozen · $295M | Reiterated | Buy | — | — | −9.6%next day −6.6% · 5 days −5.1% | ↗ |
| Apr 29on TipRanks 23:45 | CBIOIWMCrescent Biopharma · $464M | Reiterated | Buy | — | — | +5.8%next day −19.5% · 5 days −21.3% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗